Stocks
Onspira Therapeutics, Inc.OSPT
HealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for diseases with high unmet need, including oncology and rare genetic disorders. Its pipeline targets specific molecular pathways, with lead candidates in early-to-mid-stage trials. Investors track OSPT for its potential in precision medicine and upcoming clinical data catalysts.
Congressional Interest in Onspira Therapeutics, Inc. (OSPT)
1 member of Congress has disclosed 1 trade in Onspira Therapeutics, Inc. (OSPT), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading OSPT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-06-15 | SUSAN BROOKS | buy | $15K-$50K |